Methylglyoxal further impairs adipose tissue metabolism after partial decrease of blood supply

Archives of Physiology and Biochemistry

Volumn 119, Issue 5, 2013, Pages 209-218

  Rodrigues, Tiago ^a   Matafome, Paulo ^a   Seiça, Raquel ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Adipose tissue; Glycation; Metabolism; Methylglyoxal; Vascular dysfunction

Indexed keywords

BIOLOGICAL MARKER; METHYLGLYOXAL;

ADIPOSE TISSUE; ANIMAL; ARTICLE; CYTOLOGY; DRUG EFFECT; EPIDIDYMIS; GLYCOSYLATION; ISCHEMIA; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; RAT; SIGNAL TRANSDUCTION; TIME; VASCULARIZATION; WISTAR RAT;

ADIPOSE TISSUE; ANIMALS; BIOLOGICAL MARKERS; EPIDIDYMIS; GLYCOSYLATION; ISCHEMIA; MALE; POSTOPERATIVE COMPLICATIONS; PYRUVALDEHYDE; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84887938844     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813455.2013.812121     Document Type: Article

References (39)

1. Akhand A, Hossain K, Mitsui H, et al. (2001). Glyoxal and methylglyoxal trigger distinct signals for map family kinases and caspase activation in human endothelial cells. Free Rad Biol Med, 31: 20-30. (Pubitemid 32568420)
2. Balistreri C, Caruso C, Candore G. (2010). The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Med Inflam, 10:1-19.
3. Bento C, Marques F, Fernandes R, Pereira P. (2010a). Methylglyoxal alters the function and stability of critical components of the protein quality control. PLoS ONE, 5:e13007.
4. Bento CF, Fernandes R, Matafome P, et al. (2010b). Methylglyoxalinduced imbalance in the ratio of vascular endothelial growth factor to angiopoietin 2 secreted by retinal pigment epithelial cells leads to endothelial dysfunction. Exp Physiol, 95:955-70.
5. Berggreen C, Gormand A, Omar B, et al. (2009). Protein kinase B activity is required for the effects of insulin on lipid metabolism in adipocytes. Am J Physiol Endo Metab, 296:E635-46.
6. Brownlee M. (2005). The pathobiology of diabetic complications: A unifying mechanism. Diabetes, 54:1615-25. (Pubitemid 40770750)
7. Catarino S, Bento CF, Brito A, et al. (2012). Regulation of the expression of interleukin-8 induced by 25-hydroxycholesterol in retinal pigment epithelium cells. Acta Ophthal, 90:e255-63.
8. Chaiban JT, Bitar FF, Azar ST. (2008). Effect of chronic hypoxia on leptin, insulin, adiponectin, and ghrelin. Metab: Clin Exp, 57: 1019-22. (Pubitemid 351978059)
9. Chan W-H, Wu H-J, Shiao N-H. (2007). Apoptotic signaling in methylglyoxal-treated human osteoblasts involves oxidative stress, c-Jun N-terminal kinase, caspase-3, and p21-activated kinase 2. J Cell Biochem, 100:1056-69.
10. Chen B, Lam KSL, Wang Y, et al. (2006). Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes. Biochem Biophys Res Comm, 341:549-56. (Pubitemid 43152139)
11. Cònsol G, Moles A, Ricart-Jané D, Llobera M. (2005). An in situ perfusion protocol of rat epididymal adipose tissue useful in metabolic studies. J Lipid Res, 46:1803-8. (Pubitemid 41099349)
12. Gaens KHJ, Ferreira I, Kallen CJH, et al. (2009). Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels. J Clin Endocrin Metab, 94:5174-80.
13. Galic S, Oakhill JS, Steinberg GR. (2010). Adipose tissue as an endocrine organ. Mol Cell Endocrin, 316:129-39.
14. Goldin A, Beckman J, Schmidt AM, Creager M. (2006). Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation, 114:597-605. (Pubitemid 44199649)
15. Guilherme A, Virbasius JV, Puri V, Czech MP. (2008). Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nature Reviews. Mol Cell Biol, 9:367-77. (Pubitemid 351574198)
16. Hirasawa Y, Sakai T, Ito M, et al. (2011). Advanced-glycation-endproduct- cholesterol-aggregated-protein accelerates the proliferation of mesangial cells mediated by transforming-growth-factor-beta 1 receptors and the ERK-MAPK pathway. Euro J Pharma, 672:159-68.
17. Hosogai N, Fukuhara A, Oshima K, et al. (2007). Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes, 56:901-11. (Pubitemid 46525054)
18. Juge-Aubry CE, Henrichot E, Meier C. (2005). Adipose tissue: A regulator of inflammation. Best Practice Res Clin Endocrin Metab, 19:547-66. (Pubitemid 41823815)
19. Kim K, Song MJ, Chung J, et al. (2005). Hypoxia inhibits adipocyte differentiation in a HDAC-independent manner. Biochem Biophys Res Comm, 333:1178-84. (Pubitemid 40910127)
20. Koka V, Wang W, Huang XR, et al. (2006). Advanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complications. Circulation, 113:1353-60. (Pubitemid 43739457)
21. Manneras-Holm L, Krook A. (2012). Targeting adipose tissue angiogenesis to enhance insulin sensitivity. Diabetologia, 55:2562-4.
22. Matafome P, Santos-Silva D, Crisóstomo J, et al. (2012). Methylglyoxal causes structural and functional alterations in adipose tissue independently of obesity. Arch Physiol Biochem, 118:58-68.
23. Matafome P, Sena C, Seiça R. (2013). Methylglyoxal, obesity, and diabetes. Endocrine, 43(3):472-84.
24. Maury E, Brichard SM. (2010). Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrin, 314:1-16.
25. Negre-Salvayre A, Salvayre R, Augé N, et al. (2009). Hyperglycemia and glycation in diabetic complications. Antioxidants & Redox Sig, 11: 3071-109.
26. Nunn AV, Bell J, Barter P. (2007). The integration of lipid-sensing and anti-inflammatory effects: how the PPARs play a role in metabolic balance. Nuclear Receptor, 5:1-13.
27. Omar B, Zmuda-Trzebiatowska E, Manganiello V, et al. (2009). Regulation of AMP-activated protein kinase by cAMP in adipocytes: roles for phosphodiesterases, protein kinase B, protein kinase A, Epac and lipolysis. Cellular Sig, 21:760-6.
28. Rabbani N, Thornalley PJ. (2012). Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome. Amino Acids, 42:1133-42.
29. Rajala MW, Scherer PE. (2003). Minireview: The adipocyte-at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology, 144:3765-73. (Pubitemid 37088727)
30. Regazzetti C, Peraldi P, Grémeaux T, et al. (2009). Hypoxia decreases insulin signaling pathways in adipocytes. Diabetes, 58:95-103.
31. Rodrigues T, Paulo M, Santos-Silva D, et al. (2013). Reduction of methylglyoxal-induced glycation by pyridoxamine improves adipose tissue microvascular lesions. J Diabetes Res, 2013; 690650.
32. Rutkowski JM, Davis KE, Scherer PE. (2009). Mechanisms of obesity and related pathologies: The macro-and microcirculation of adipose tissue. FEBS J, 276:5738-46.
33. Sena C, Matafome P, Crisóstomo J, et al. (2012). Methylglyoxal promotes oxidative stress and endothelial dysfunction. Pharma Res: Official J Italian Pharm Soc, 65:497-506.
34. Strissel K, Stancheva Z, Miyoshi H. (2007). Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes, 56: 2910-18. (Pubitemid 350223625)
35. Trayhurn P, Wang B, Wood IS. (2008). Hypoxia in adipose tissue: A basis for the dysregulation of tissue function in obesityBrit J Nutrition, 100:227-35.
36. Trayhurn P, Wood IS. (2004). Adipokines: Inflammation and the pleiotropic role of white adipose tissue. Brit J Nutrition, 92: 347-355. (Pubitemid 40277057)
37. Vázquez-Vela MEF, Torres N, Tovar AR. (2008). White adipose tissue as endocrine organ and its role in obesity. Arch Med Res, 39:715-28.
38. Ye J. (2010). Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obesity, 33:235-47.
39. Ye J, Gao Z, Yin J, He Q. (2007). Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J PhysiolEndocrin Metab, 293: E1118-28. (Pubitemid 47535846)